A detailed history of Clean Yield Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Clean Yield Group holds 4,546 shares of ABBV stock, worth $832,281. This represents 0.3% of its overall portfolio holdings.

Number of Shares
4,546
Previous 4,697 3.21%
Holding current value
$832,281
Previous $805,000 11.43%
% of portfolio
0.3%
Previous 0.32%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$163.84 - $199.33 $24,739 - $30,098
-151 Reduced 3.21%
4,546 $897,000
Q2 2024

Jul 10, 2024

BUY
$154.79 - $180.76 $1,702 - $1,988
11 Added 0.23%
4,697 $805,000
Q1 2024

May 29, 2024

SELL
$159.82 - $182.1 $4,794 - $5,463
-30 Reduced 0.64%
4,686 $853,000
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $13,251 - $16,490
-100 Reduced 2.08%
4,716 $635,000
Q1 2023

Apr 26, 2023

SELL
$144.61 - $166.54 $44,973 - $51,793
-311 Reduced 6.07%
4,816 $767,000
Q3 2022

Oct 31, 2022

SELL
$134.21 - $153.93 $108,173 - $124,067
-806 Reduced 13.59%
5,127 $688,000
Q1 2022

Apr 25, 2022

BUY
$131.98 - $163.75 $279,797 - $347,150
2,120 Added 55.6%
5,933 $962,000
Q4 2021

Jan 24, 2022

SELL
$107.43 - $135.93 $16,544 - $20,933
-154 Reduced 3.88%
3,813 $516,000
Q3 2021

Oct 27, 2021

BUY
$106.4 - $120.78 $86,928 - $98,677
817 Added 25.94%
3,967 $428,000
Q2 2021

Jul 26, 2021

BUY
$105.21 - $117.21 $58,917 - $65,637
560 Added 21.62%
3,150 $355,000
Q1 2021

Apr 26, 2021

SELL
$102.3 - $112.62 $10,230 - $11,262
-100 Reduced 3.72%
2,590 $280,000
Q4 2020

Jan 26, 2021

SELL
$80.49 - $108.67 $88,539 - $119,537
-1,100 Reduced 29.02%
2,690 $288,000
Q3 2020

Oct 16, 2020

BUY
$85.91 - $100.83 $8,591 - $10,083
100 Added 2.71%
3,790 $332,000
Q2 2020

Jul 22, 2020

SELL
$73.37 - $98.18 $14,674 - $19,636
-200 Reduced 5.14%
3,690 $362,000
Q1 2020

Apr 20, 2020

SELL
$64.5 - $97.79 $509,550 - $772,541
-7,900 Reduced 67.01%
3,890 $296,000
Q3 2019

Oct 23, 2019

SELL
$62.98 - $75.72 $6,298 - $7,572
-100 Reduced 0.84%
11,790 $893,000
Q2 2019

Jul 22, 2019

BUY
$65.7 - $83.98 $23,454 - $29,980
357 Added 3.1%
11,890 $865,000
Q1 2019

Apr 24, 2019

BUY
$77.14 - $90.79 $23,142 - $27,237
300 Added 2.67%
11,533 $929,000
Q4 2018

Jan 23, 2019

BUY
$77.85 - $96.01 $58,387 - $72,007
750 Added 7.15%
11,233 $1.04 Million
Q1 2018

Apr 23, 2018

BUY
$92.01 - $123.21 $82,809 - $110,889
900 Added 9.39%
10,483 $992,000
Q3 2017

Oct 11, 2017

BUY
$69.85 - $89.22 $669,372 - $854,995
9,583
9,583 $852,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Clean Yield Group Portfolio

Follow Clean Yield Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.